Navigation Links
Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards
Date:10/10/2008

TAIZHOU, Jiangsu, CHINA, Oct. 10 /Xinhua-PRNewswire/ -- Beike Biotechnology Co. Ltd., ( http://www.beikebiotech.com ) a global leader in stem cell research and treatment through evidence-based medicine, announced today it has signed eight separate mutual cooperation agreements with some of China and the world's most outstanding stem cell research organizations. As part of the agreements, Beike has also established a "Stem Cell Expert Advisory Committee" and a separate "Data and Safety Monitoring Board (DSMB)" to oversee future Beike-sponsored research.

The eight accords, initially discussed at the recently completed 2008 China Stem Cell Technology Forum held at China Medical City, will deepen Beike's leadership in providing safe, effective, and cutting-edge stem cell treatments to patients from all over the world. The eight organizations that will share resources, research information, and best practices with Beike Biotech are: AELCELL of Stanford, California, Nanjing Medical University, the China Medical City, Hua Zhong Technical University, the University of Texas Health Science Center at Houston, Jiangsu People's Hospital, the No. 2 Hospital of Nanjing Medical University, and the Wu Hu City No. 2 People's Hospital in Anhui, China. These mutual cooperation agreements vastly increase Beike's ability to incorporate real-time research information into its network, bolstering Beike's position as the Asian leader and one of the world's foremost biotechnology companies providing stem cell solutions for a range of ailments.

Dr. Sean Hu, the Chairman of Beike Biotech, stated, "Beike realizes there is definitely strength in numbers when it comes to discovering the latest and best stem cell technologies that will effectively fight a range of terrible diseases. Therefore, we are extremely enthusiastic to be cooperating with eight of the world's leading stem cell research centers, so that together we can more rapidly bring effective treatments to those who need it today."

On the sidelines of the Forum, Beike also sought out a number of highly respected doctors from China and abroad to serve on a newly established "Data and Safety Monitoring Board (DSMB)" that will oversee Beike-sponsored stem cell research. The DSMB, which is Chaired by Dr. Li Zhanquan of China's Liaoning People's Hospital and includes Dr. Geng Yongjian of the University of Texas Medical School, will operate in line with the spirits of the Declaration of Helsinki, the Council of International Organizations of Medical Sciences (CIOMS), International Ethical Guidelines for Biomedical Research Involving Human Subjects, and Guidelines for Good Clinical Practice from the World Health Organization (WHO) and The International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use. Members of the DSMB will review data protocols and enforce stringent, international safety standards for specific clinical trials Beike plans to conduct this year.

Additionally, a "Stem Cell Expert Advisory Committee" was established from among China's top science institutions to provide advice to Beike on ethical issues covering basic and clinical stem cell research, as well scrutinize clinical trial project teams for sound data monitoring and best safety practices. The five rotating Members of the Stem Cell Expert Advisory Committee, which initially include Dr. Wang Zhonggao of the prestigious Chinese Academy of Sciences and Dr. Chen Hao Zhu of the China Engineering Academy, will provide guidance on ethical issues and scrutinize clinical trials for safety monitoring, also adhering to all international protocols stated above such as Helsinki, CIOMS, WHO, and ICH.

Dr. Sean Hu further said, "We at Beike are committed to providing clarity and resonance in the newly unfolding stem cell research and treatment fields. We seek to set the global standard, demonstrating that everything we do is genuine, safe, and of world-class quality. This is why we will continue to increase transparency, welcoming international standard oversight systems which will serve to make the Beike team and our services even better."

About Beike Biotechnology Company Limited

Beike is a biotechnology company founded in July 2005 with capital from Beijing University, Hong Kong University of Science and Technology and Shenzhen City Hall. That year it commercialized stem cell technology that had been in research since 1999. The research and clinical work comes from collaborations with leading institutions in China including Tsinghua University, Beijing University, Hong Kong University of Science and Technology, No. 3 Army Medical University, Zhongshan Medical University, Guiyang Medical College and Zhengzhou University. Over 250 patients each month are treated with Beike's stem cells in leading hospitals throughout China. Patient experiences from treatments can be found at Stem Cell China News ( http://www.stemcellschina.com ).


'/>"/>
SOURCE Beike Biotech Company, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. DuPont Leaders Brief Investors on Agriculture Businesses
2. Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion
3. N.C. Takes Biofuels Leadership, Establishes New Endeavor With $5 Million State Appropriation
4. Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry
5. United BioSource Acquires Caro Research, Leader in Simulation Modeling
6. KGI and Smith College Establish Leadership Forum for Women in Bioscience
7. RF Pain Management Industry Leaders Cotop International and NeuroTherm, Inc. Agree to Merge
8. Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference
9. Assay Designs(TM) Announces Additions to the Leadership Team
10. Deloitte Leadership Offers Crucial Convergence Considerations for Life Sciences Companies
11. 2007 Global Survey Identifies Characteristics of Supply Chain Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... ... February 04, 2016 , ... ... compliance training, today announced an interactive FDA compliance training course, ... (Regulatory Affairs Professional Society) accredited interactive course on Morf Playbook—now conveniently available on ...
(Date:2/4/2016)...  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), the ... Edward Lanphier , Sangamo,s president and chief executive officer, ... ZFP Therapeutic ® development programs and an overview ... on Thursday, February 11, 2016, at the Leerink Partners ... is being held in New York ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... Club, takes place February 5-6 at the University’s student center, Kehr Union, ... such as workshops and competitions for ample networking, learning and collaborating opportunities. ...
(Date:2/4/2016)... , Feb. 4, 2016  CytoSorbents Corporation (NASDAQ: ... commercializing its flagship CytoSorb® blood filter to treat ... around the world, announced that CEO Dr. ... the Source Capital Group,s 2016 Disruptive Growth & ... the company.  Conference Presentation Details: ...
Breaking Biology Technology:
(Date:1/8/2016)... 8, 2016 NXTD ), a ... ® , a privately held leading direct seller of ... 5000 fastest-growing company announced that on December 31, ... million in Nxt-ID to develop a proprietary new wireless ... ® , a unique smart wallet that serves to ...
(Date:1/7/2016)... LONDON , Jan. 7, 2016 ... demand for biopharmaceutical products such as biologics and ... pressure to reduce healthcare expenditure, growing demand for ... growing aging population. Biosimilars are similar versions of ... with regards to their quality, safety, and efficacy. ...
(Date:1/6/2016)... Calif. , Jan. 6, 2016  Varam Capital, ... as their trusted partner to deliver advanced authentication solutions ... financial services to the poor. A loan of a ... their lives, giving them the ability to purchase livestock ... to make clothing, or stock for a local store. ...
Breaking Biology News(10 mins):